ATE147167T1 - Oxidative denaturierung von eiweissanalyten - Google Patents

Oxidative denaturierung von eiweissanalyten

Info

Publication number
ATE147167T1
ATE147167T1 AT90112199T AT90112199T ATE147167T1 AT E147167 T1 ATE147167 T1 AT E147167T1 AT 90112199 T AT90112199 T AT 90112199T AT 90112199 T AT90112199 T AT 90112199T AT E147167 T1 ATE147167 T1 AT E147167T1
Authority
AT
Austria
Prior art keywords
protein
protein analytes
oxidizing agent
oxidative denaturation
disulfide
Prior art date
Application number
AT90112199T
Other languages
German (de)
English (en)
Inventor
James Elting
Heinz Koelbl
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE147167T1 publication Critical patent/ATE147167T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT90112199T 1989-07-10 1990-07-06 Oxidative denaturierung von eiweissanalyten ATE147167T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/377,680 US5061790A (en) 1989-07-10 1989-07-10 Oxidative denaturation of protein analytes

Publications (1)

Publication Number Publication Date
ATE147167T1 true ATE147167T1 (de) 1997-01-15

Family

ID=23490110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112199T ATE147167T1 (de) 1989-07-10 1990-07-06 Oxidative denaturierung von eiweissanalyten

Country Status (18)

Country Link
US (1) US5061790A (fr)
EP (1) EP0407813B1 (fr)
JP (1) JP2915970B2 (fr)
KR (1) KR910003380A (fr)
AT (1) ATE147167T1 (fr)
AU (1) AU633115B2 (fr)
CA (1) CA2019671C (fr)
DE (1) DE69029540T2 (fr)
DK (1) DK0407813T3 (fr)
ES (1) ES2095847T3 (fr)
FI (1) FI903464A0 (fr)
GR (1) GR3022906T3 (fr)
IE (1) IE902493A1 (fr)
IL (1) IL94993A (fr)
NO (1) NO902833L (fr)
NZ (1) NZ234396A (fr)
PT (1) PT94633B (fr)
ZA (1) ZA905360B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740223B1 (fr) * 1995-10-19 1997-11-14 Commissariat Energie Atomique Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2403292C (fr) * 2000-04-06 2011-02-08 Panacea Pharmaceuticals, Llc Systeme d'administration microbienne
WO2003002908A1 (fr) * 2000-06-26 2003-01-09 Reveo, Inc. Eclairage par l'arriere pour afficheur a cristaux liquides, a recyclage de flux lumineux tres efficace
DE10054055A1 (de) * 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
US7460960B2 (en) * 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US9557325B2 (en) * 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
WO2004111608A2 (fr) 2003-06-09 2004-12-23 Mcintyre John A Procede permettant de modifier la specificite de liaison des proteines plasmiques au moyen de reactions d'oxydation-reduction
US7892751B2 (en) * 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
CN101627306B (zh) * 2007-03-08 2014-02-05 霍夫曼-拉罗奇有限公司 Slim-1在心力衰竭评估中的用途
KR101322247B1 (ko) * 2007-09-06 2013-10-25 삼성전자주식회사 진공청소기용 흡입브러시 및 그 높이조절방법
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
US20130189707A1 (en) * 2010-01-26 2013-07-25 Svetlana Alexandrovna Sergeeva Method of determination of autoantibody level by means of enzyme immunoassay
CA2863635A1 (fr) * 2012-02-02 2013-08-08 Perfinity Biosciences, Inc. Systeme de reconnaissance et de quantification base sur des selecteurs et procede pour multiples analytes au cours d'une seule et meme analyse

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448530C3 (de) * 1974-10-11 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides

Also Published As

Publication number Publication date
IL94993A0 (en) 1991-06-10
ZA905360B (en) 1991-04-24
CA2019671A1 (fr) 1991-01-10
AU633115B2 (en) 1993-01-21
KR910003380A (ko) 1991-02-27
JPH0368868A (ja) 1991-03-25
NO902833D0 (no) 1990-06-26
NZ234396A (en) 1992-02-25
PT94633B (pt) 1997-04-30
PT94633A (pt) 1991-03-20
CA2019671C (fr) 2002-08-13
DE69029540T2 (de) 1997-05-07
EP0407813A2 (fr) 1991-01-16
EP0407813B1 (fr) 1997-01-02
IE902493A1 (en) 1991-02-13
EP0407813A3 (en) 1992-11-25
FI903464A0 (fi) 1990-07-09
DE69029540D1 (de) 1997-02-13
US5061790A (en) 1991-10-29
DK0407813T3 (da) 1997-06-16
NO902833L (no) 1991-01-11
ES2095847T3 (es) 1997-03-01
IL94993A (en) 1994-05-30
GR3022906T3 (en) 1997-06-30
JP2915970B2 (ja) 1999-07-05
AU5872790A (en) 1991-01-10

Similar Documents

Publication Publication Date Title
DE69029540D1 (de) Oxidative Denaturierung von Eiweissanalyten
ATE95068T1 (de) Modifizierte antikoerper.
ATE108186T1 (de) Kontrollierte oxydation von mikrobiell hergestellten cysteine enthaltenden proteinen.
ATE114156T1 (de) Herstellung von proteinen in aktiver form.
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
FI93842B (fi) Menetelmä proteiinien renaturoimiseksi
DE58904713D1 (de) Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
PT93178A (pt) Agente proteico anticanceroso
DE69232669D1 (de) Mit gp11b/iiia reaktive humane antikörper
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
ATE2049T1 (de) Mittel zur therapie von immunkomplexerkrankungen.
DE3584926D1 (de) Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
KR900018678A (ko) 엘라스타제-1의 면역 분석법
ATE135821T1 (de) Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee